Balance Sheets That Can Survive Anything

The Setup

The Wealth Engine Pro Financial Health score evaluates 100 data points across a company's balance sheet: cash and equivalents, short- and long-term debt, interest coverage, current ratio, free cash flow consistency, working capital trends, and the ability to service obligations under stress. A score above 80 means a company has financial flexibility that most of the market does not. A score above 85 means the balance sheet is a competitive weapon.

The first two installments of The Five used different primary filters: Moat score for dividend durability and the disconnect between analyst consensus and platform data. This week, the filter is Financial Health. We set the threshold at 83/100 and looked for companies with market capitalizations above $5 billion. That screen returned 38 companies. From those 38, we selected five that offer sector diversification, a range of business models, and balance sheets so strong that a recession, a credit crunch, or a sustained period of elevated rates would not change their strategic position. In several cases, it would improve it: companies with cash and no debt can acquire competitors at distressed prices when the market turns.

ResMed (RMD)

ResMed (RMD) carries the highest Financial Health score of any company with a market cap above $5 billion on the entire Wealth Engine Pro platform: 91 out of 100. The Company Strength rating is 86.4 (Elite). The Moat score is 14 out of 15. These are not cherry-picked metrics. This is a company where every systematic measure points in the same direction.

The balance sheet tells you why. ResMed ended Q3 FY2026 with $1.66 billion in cash and $665 million in total debt, making it a net cash company. Operating cash flow for the quarter was $554 million, more than covering the $399 million in net income. That cash conversion above 100% means the reported earnings are real, not accounting constructs.

The business itself is a recession-proof franchise. ResMed makes CPAP machines and masks for sleep apnea, a condition affecting an estimated one billion people globally, most of whom are undiagnosed. The devices require ongoing consumable replacement (masks, tubing, filters), creating a recurring revenue stream that does not depend on consumer sentiment or housing markets. Revenue grew 11% in Q3 to $1.43 billion, with gross margins expanding 290 basis points to 62.2%. EPS grew 21%. When a company is growing earnings at 20%+ with a P/E of 20, a net cash position, and a Health score of 91, the data is telling you something the market is not fully pricing.

Intuit (INTU)

Intuit (INTU) is the only stock on this list that the Wealth Engine Pro platform rates as undervalued. The current price sits 15% below the calculated fair value of $443.95. For an Elite-rated company with a Financial Health score of 86, a Moat of 13/15, and a Bullish outlook, that pricing gap is worth paying attention to.

The balance sheet anchoring that score: $6.8 billion in cash and investments against $6.2 billion in debt as of April 2026. That is roughly neutral net debt, but the cash flow generation changes the picture entirely. Q3 FY2026 revenue hit $8.56 billion, with GAAP operating income of $4.0 billion (+8%) and non-GAAP EPS of $12.80 (+10%). TurboTax revenue grew to $4.4 billion. QuickBooks Online Accounting revenue grew 22%. Credit Karma revenue hit $631 million (+15%). The board just authorized a new $8 billion share repurchase program.

What makes Intuit a fortress is the nature of the revenue. People file taxes in recessions. Small businesses need accounting software especially when cash gets tight and every dollar needs tracking. TurboTax's market position is structurally entrenched, with switching costs that increase every year a customer files through the platform. QuickBooks has become the default operating system for small business finance. At 18.6x earnings with these fundamentals, the market is pricing Intuit as if something is wrong. The Financial Health score says nothing is.

Monster Beverage (MNST)

Monster Beverage (MNST) has zero debt. Not low debt. Not manageable debt. Zero. The debt-to-equity ratio is 0.0%. For an $87 billion company, that is extraordinary. The company ended Q1 2026 with $2.04 billion in cash and $945 million in short-term investments, totaling nearly $3 billion in liquid assets with nothing owed to any creditor. In a market where most large-cap companies carry billions in long-term debt, Monster operates as if leverage were a disease to be avoided.

The Q1 2026 results showed the business model in peak form. Revenue surged 27% to $2.35 billion, beating estimates by nearly 9%. Operating income rose 28% to $730 million. International sales climbed 45% to $1.06 billion, now representing 45% of total revenue. Energy drink unit sales in the U.S. grew 27.6%. The global energy drink category continues to expand, and Monster's distribution partnership with The Coca-Cola Company gives it shelf space and logistics that no challenger can easily replicate. The Moat score of 14/15 reflects that reality.

The bear case on Monster is the P/E: 43x is not cheap. But the premium buys you something specific: a company that cannot be forced into a bad decision by creditors, that generates enough free cash flow ($2 billion TTM) to fund buybacks and growth internally, and that sells a product people reach for regardless of whether the economy is expanding or contracting. Energy drinks are a small-dollar indulgence. They are not the line item households cut when the budget gets tight. That is why Monster has compounded through every macro environment of the last 20 years, and why the balance sheet has never needed debt to do it.

Garmin (GRMN)

Garmin (GRMN) is the company on this list that nobody expects to see, and that is exactly the point. The consumer electronics company best known for GPS devices has quietly built one of the cleanest balance sheets in the S&P 500: debt-free, with $4.3 billion in cash and marketable securities, and a free cash flow run rate that generated $469 million in Q1 2026 alone.

The business is more diversified than most investors realize. Five operating segments (Fitness, Outdoor, Marine, Aviation, Auto OEM) mean Garmin is not dependent on any single market or product cycle. In Q1 2026, consolidated revenue grew 14% to a record $1.75 billion. The Fitness segment exploded, up 42% to $547 million, driven by wearable demand and new product launches like the Forerunner 70 and 170. Operating income hit a first-quarter record of $432 million, up 30%, with operating margins expanding 290 basis points to 24.6%. Gross margins reached 59.4%.

Garmin also just announced a 17% dividend increase and a new $500 million share repurchase program, funded entirely from operating cash flow. No debt issuance. No balance sheet engineering. Just cash from operations returned to shareholders. The Moat score of 13/15 captures the brand loyalty and switching costs that keep Garmin's premium customer base coming back. Readers of our Case for Boring Utilities and our analysis of Dividend Machines will recognize the pattern: the companies nobody talks about are often the ones compounding most quietly.

Arista Networks (ANET)

Arista Networks (ANET) has $12.35 billion in cash and marketable securities and zero debt. Let that number sit for a moment. A networking equipment company with more cash on hand than many S&P 500 companies generate in a decade of operations. Operating margins run at 47.8%. Net margins are 40.9%. Q1 2026 operating cash flow hit $1.69 billion, a single-quarter record. The Company Strength score is 86.0 (Elite), the highest on this list, with a Moat score of 14/15.

The business is the backbone of modern data center networking. Arista makes the high-speed Ethernet switches that connect servers in hyperscale data centers run by companies like Microsoft, Meta, and Google. Revenue grew 35% in Q1 to $2.71 billion, beating guidance by over $100 million. The company raised its full-year revenue forecast to $11.5 billion and its AI networking target to $3.5 billion, more than doubling AI-related sales year over year. Customer satisfaction, measured by net promoter score, sits at 89, meaning 94% of customers rate Arista positively.

The P/E of 54x is the highest on this list, and for a balance-sheet-focused article, that matters. But the balance sheet is the reason the premium is defensible. A company with $12 billion in cash, no debt, and 48% operating margins does not need external financing to invest in R&D, expand facilities, or acquire competitors. When the credit markets freeze (and the credit data suggests they are heading that direction), Arista can keep building while leveraged competitors are forced to cut. That asymmetry is what a fortress balance sheet buys you.

What the Wealth Engine Scores Say

Here is what the platform's systematic scoring shows for all five stocks right now.

The contrast with last week could not be sharper. Where The Five: Stocks Wall Street Loves showed five Weak/Bearish companies, this list is wall-to-wall green: all five Elite, all five Bullish, three near or below fair value. Two (GRMN and ANET) trade at premiums, but the strength of their fundamentals explains why.

These scores are systematic. They evaluate companies based on reported financials, balance sheet quality, moat characteristics, and valuation models (DCF, peer comparison, earnings power). They measure what a company is today, not what it might become.

In this case, the editorial thesis and the platform scores point in the same direction. When both the systematic data and the qualitative analysis agree that these balance sheets are fortresses, that convergence is the strongest signal The Five has produced yet. Research any of these stocks yourself on the platform and see the full picture.

What Didn't Make the List

Lam Research (LRCX) had the second-highest Financial Health score in the screen at 89/100 and an Elite Company Strength of 84.6. The balance sheet is unquestionably strong. The reason it missed: the stock trades 62% above its calculated fair value with only a Neutral outlook. For a list about surviving anything, paying 62% above intrinsic value creates the very risk the balance sheet is supposed to protect against. Lam's fortress is real. The entry price is not.

NVIDIA (NVDA) scores 83/100 on Financial Health and 84.2 (Elite) on Company Strength. The balance sheet is exceptional and the business is arguably the most important in the AI infrastructure stack. But at 38% above fair value and a market cap exceeding $5 trillion, the stock trades on forward expectations that go well beyond what the balance sheet can anchor. A balance sheet that can survive anything does not help if the purchase price already assumes everything goes right.

Meta Platforms (META) has a Financial Health score of 84/100, rebuilt its balance sheet during the 2023 "Year of Efficiency," and generates enormous free cash flow. It missed the final five because the 33% premium above fair value and the capital intensity of Reality Labs spending create a valuation overhang that the Health score alone cannot resolve.

What Could Go Wrong

A strong balance sheet protects against financial distress. It does not protect against overpaying. Two of these five stocks (GRMN and ANET) trade above the platform's fair value estimates. If the market broadly reprices from growth to value, or if a recession compresses earnings multiples, even fortress companies can see significant drawdowns. Owning a great company at the wrong price is still a risk.

ResMed faces GLP-1 drug headlines. Ozempic and similar medications have been framed as potential threats to CPAP demand, since weight loss can reduce sleep apnea severity. So far the data has not supported a meaningful impact on device sales (Q3 revenue grew 11%), but the narrative creates periodic selling pressure. Intuit faces AI disruption risk: if conversational AI tools eventually handle tax filing and bookkeeping natively, the TurboTax moat could narrow. Monster's growth in international markets exposes it to currency risk and potential regulatory action on energy drink marketing in the EU and developing markets.

The macro risk cuts both ways. These companies benefit from a downturn because they can invest while others retrench. But if the economy avoids a recession entirely and credit stays loose, the balance sheet premium these stocks command becomes less valuable relative to higher-growth, higher-leverage competitors. The fortress matters most when it is tested. If it is never tested, the market may not reward the discipline.

The Bottom Line

Three weeks of The Five have now covered three different lenses on the same question: what does the data actually say? The dividend list filtered by Moat score and found companies whose payouts are protected by real competitive advantages. The Wall Street disconnect list filtered by the gap between analyst narratives and platform scores and found companies where the premium has no data behind it. This list filtered by Financial Health and found companies whose balance sheets can fund growth, return capital, and weather crises without asking anyone's permission.

ResMed, Intuit, Monster Beverage, Garmin, and Arista Networks hold a combined $27 billion in cash and investments. Three carry zero debt. All five are rated Elite. All five have Bullish outlooks. Two trade near or below fair value. The data is not subtle about what it thinks of these balance sheets.

That is the Wealth Engine Pro approach: start with the numbers, apply a systematic filter, and let the data surface what deserves attention. No narratives about macro predictions. No speculation about what the Fed might do. Just financial statements, scored systematically, telling you which companies have built something that a recession, a credit crunch, or a decade of elevated rates cannot break. Look them up on the platform. The scores speak for themselves.